| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |